Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2021-11-24 2021-11-15
Drug Identification Number 00777838 00777838
Brand name PEGLYTE POWDER PEGLYTE POWDER
Common or Proper name PEGLYTE POWDER PEGLYTE POWDER
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE MACROGOL POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE MACROGOL
Strength(s) 3.05G 5.85G 6.76G 22.96G 238.18G 3.05G 5.85G 6.76G 22.96G 238.18G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 4X70G 4X70G
ATC code A06AD A06AD
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-09 2021-11-09
Estimated end date 2021-12-10 2021-12-10
Actual end date 2021-11-24
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments